Literature DB >> 32564657

Luminal microbiota related to Crohn's disease recurrence after surgery.

Amy L Hamilton1, Michael A Kamm1, Peter De Cruz1,2, Emily K Wright1, Hai Feng3,4,5, Josef Wagner4,6, Joseph J Y Sung3, Carl D Kirkwood4,7, Michael Inouye8, Shu-Mei Teo8.   

Abstract

BACKGROUND: Microbial factors are likely to be involved in the recurrence of Crohn's disease (CD) after bowel resection. We investigated the luminal microbiota before and longitudinally after surgery, in relation to disease recurrence, using 16S metagenomic techniques.
METHODS: In the prospective Post-Operative Crohn's Endoscopic Recurrence (POCER) study, fecal samples were obtained before surgery and 6, 12, and 18 months after surgery from 130 CD patients. Endoscopy was undertaken to detect disease recurrence, defined as Rutgeerts score ≥i2, at 6 months in two-thirds of patients and all patients at 18 months after surgery. The V2 region of the 16S rRNA gene was sequenced using Illumina MiSeq. Cluster analysis was performed at family level, assessing microbiome community differences between patients with and without recurrence.
RESULTS: Six microbial cluster groups were identified. The cluster associated with maintenance of remission was enriched for the Lachnospiraceae family [adjusted OR 0.47 (0.27-0.82), P = .007]. The OTU diversity of Lachnospiraceae within this cluster was significantly greater than in all other clusters. The cluster enriched for Enterobacteriaceae was associated with an increased risk of disease recurrence [adjusted OR 6.35 (1.24-32.44), P = .026]. OTU diversity of Enterobacteriaceae within this cluster was significantly greater than in other clusters.
CONCLUSIONS: Luminal bacterial communities are associated with protection from, and the occurrence of, Crohn's disease recurrence after surgery. Recurrence may relate to a higher abundance of facultatively anaerobic pathobionts from the Enterobacteriaceae family. The ecologic change of depleted Lachnospiraceae, a genus of butyrate-producing bacteria, may permit expansion of Enterobacteriaceae through luminal environmental perturbation.

Entities:  

Keywords:  Crohn’s disease; Microbiota; enterobacteriaceae; microbiome; surgery

Year:  2020        PMID: 32564657      PMCID: PMC7524166          DOI: 10.1080/19490976.2020.1778262

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  68 in total

1.  Risk factors for surgery and postoperative recurrence in Crohn's disease.

Authors:  O Bernell; A Lapidus; G Hellers
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  Effect of pH and antibiotics on microbial overgrowth in the stomachs and duodena of patients undergoing percutaneous endoscopic gastrostomy feeding.

Authors:  Graeme A O'May; Nigel Reynolds; Aileen R Smith; Aileen Kennedy; George T Macfarlane
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

Review 3.  An integrative view of microbiome-host interactions in inflammatory bowel diseases.

Authors:  Marta Wlodarska; Aleksandar D Kostic; Ramnik J Xavier
Journal:  Cell Host Microbe       Date:  2015-05-13       Impact factor: 21.023

Review 4.  The first 1000 cultured species of the human gastrointestinal microbiota.

Authors:  Mirjana Rajilić-Stojanović; Willem M de Vos
Journal:  FEMS Microbiol Rev       Date:  2014-06-27       Impact factor: 16.408

Review 5.  Mechanisms of inflammation-driven bacterial dysbiosis in the gut.

Authors:  M Y Zeng; N Inohara; G Nuñez
Journal:  Mucosal Immunol       Date:  2016-08-24       Impact factor: 7.313

6.  Gut inflammation provides a respiratory electron acceptor for Salmonella.

Authors:  Sebastian E Winter; Parameth Thiennimitr; Maria G Winter; Brian P Butler; Douglas L Huseby; Robert W Crawford; Joseph M Russell; Charles L Bevins; L Garry Adams; Renée M Tsolis; John R Roth; Andreas J Bäumler
Journal:  Nature       Date:  2010-09-23       Impact factor: 49.962

7.  Infliximab Reduces Endoscopic, but Not Clinical, Recurrence of Crohn's Disease After Ileocolonic Resection.

Authors:  Miguel Regueiro; Brian G Feagan; Bin Zou; Jewel Johanns; Marion A Blank; Marc Chevrier; Scott Plevy; John Popp; Freddy J Cornillie; Milan Lukas; Silvio Danese; Paolo Gionchetti; Stephen B Hanauer; Walter Reinisch; William J Sandborn; Dario Sorrentino; Paul Rutgeerts
Journal:  Gastroenterology       Date:  2016-03-03       Impact factor: 22.682

8.  Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial.

Authors:  Geert R D'Haens; Severine Vermeire; Gert Van Assche; Maja Noman; Isolde Aerden; Gust Van Olmen; Paul Rutgeerts
Journal:  Gastroenterology       Date:  2008-07-16       Impact factor: 22.682

9.  A microbial signature for Crohn's disease.

Authors:  Victoria Pascal; Marta Pozuelo; Natalia Borruel; Francesc Casellas; David Campos; Alba Santiago; Xavier Martinez; Encarna Varela; Guillaume Sarrabayrouse; Kathleen Machiels; Severine Vermeire; Harry Sokol; Francisco Guarner; Chaysavanh Manichanh
Journal:  Gut       Date:  2017-02-07       Impact factor: 23.059

10.  Endospore forming bacteria may be associated with maintenance of surgically-induced remission in Crohn's disease.

Authors:  Michael R Laffin; Troy Perry; Heekuk Park; Patrick Gillevet; Masoumeh Sikaroodi; Gilaad G Kaplan; Richard N Fedorak; Karen Kroeker; Levinus A Dieleman; Bryan Dicken; Karen L Madsen
Journal:  Sci Rep       Date:  2018-06-27       Impact factor: 4.379

View more
  7 in total

1.  Gut Microbiota Profiles and Microbial-Based Therapies in Post-operative Crohn's Disease: A Systematic Review.

Authors:  Xiaojun Zhuang; Zhenyi Tian; Na Li; Ren Mao; Xiaozhi Li; Min Zhao; Shanshan Xiong; Zhirong Zeng; Rui Feng; Minhu Chen
Journal:  Front Med (Lausanne)       Date:  2021-01-28

Review 2.  Impact of Microbial Metabolites on Microbiota-Gut-Brain Axis in Inflammatory Bowel Disease.

Authors:  Davide Banfi; Elisabetta Moro; Annalisa Bosi; Michela Bistoletti; Silvia Cerantola; Francesca Crema; Fabrizio Maggi; Maria Cecilia Giron; Cristina Giaroni; Andreina Baj
Journal:  Int J Mol Sci       Date:  2021-02-05       Impact factor: 5.923

3.  Marked Response of Rat Ileal and Colonic Microbiota After the Establishment of Alzheimer's Disease Model With Bilateral Intraventricular Injection of Aβ (1-42).

Authors:  Qing Xu; Lingmiao Wen; Guihua Wei; Xiaoqin Zhao; Yanjun Liu; Wei Xiong; Tinglan Zhang; Yuqing Fan; Chunlan Chen; Chunxiao Xiang; Chang Chen; Yunhui Chen; Qiaozhi Yin; Tian-E Zhang; Zhiyong Yan
Journal:  Front Microbiol       Date:  2022-02-11       Impact factor: 5.640

Review 4.  Contribution of the Gut Microbiota to Intestinal Fibrosis in Crohn's Disease.

Authors:  Daisuke Watanabe; Nobuhiko Kamada
Journal:  Front Med (Lausanne)       Date:  2022-02-07

Review 5.  Bile Acids and the Microbiome: Making Sense of This Dynamic Relationship in Their Role and Management in Crohn's Disease.

Authors:  Aditi Kumar; Hafid O Al-Hassi; Helen Steed; Oliver Phipps; Matthew J Brookes
Journal:  Can J Gastroenterol Hepatol       Date:  2022-03-22

6.  Improvement of gut microbiome and intestinal permeability following splenectomy plus pericardial devascularization in hepatitis B virus-related cirrhotic portal hypertension.

Authors:  Yang Zhao; Rui Zhou; Ying Guo; Xi Chen; Aiyu Zhang; Jiayin Wang; Fanpu Ji; Bowen Qin; Jing Geng; Guangyao Kong; Zongfang Li
Journal:  Front Immunol       Date:  2022-09-08       Impact factor: 8.786

Review 7.  Current Use of EEN in Pre-Operative Optimisation in Crohn's Disease.

Authors:  Sharafaath Shariff; Gordon Moran; Caris Grimes; Rachel Margaret Cooney
Journal:  Nutrients       Date:  2021-12-08       Impact factor: 5.717

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.